vs
Evergy（EVRG）与登士柏西诺德（XRAY）财务数据对比。点击上方公司名可切换其他公司
Evergy的季度营收约是登士柏西诺德的1.3倍（$1.3B vs $961.0M），Evergy净利率更高（6.5% vs -15.2%，领先21.7%），登士柏西诺德同比增速更快（6.2% vs 5.3%），登士柏西诺德自由现金流更多（$60.0M vs $-530.5M），过去两年Evergy的营收复合增速更高（0.4% vs 0.4%）
Evergy Inc.是美国投资者所有的上市公用事业企业，总部位于堪萨斯州托皮卡和密苏里州堪萨斯城。公司由托皮卡的Westar Energy与堪萨斯城电力与照明公司的母公司Great Plains Energy合并组建，是堪萨斯州规模最大的电力公司，为两州超过170万户住宅、商业及工业客户提供供电服务。
登士柏西诺德是美国牙科设备及耗材制造商，业务覆盖全球120多个国家，在21个国家设有生产工厂。该公司前身为1993年Gendex公司以5.9亿美元收购登士柏国际后整合组建的企业，是全球牙科领域的重要供应商。
EVRG vs XRAY — 直观对比
营收规模更大
EVRG
是对方的1.3倍
$961.0M
营收增速更快
XRAY
高出0.9%
5.3%
净利率更高
EVRG
高出21.7%
-15.2%
自由现金流更多
XRAY
多$590.5M
$-530.5M
两年增速更快
EVRG
近两年复合增速
0.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $961.0M |
| 净利润 | $84.3M | $-146.0M |
| 毛利率 | — | 46.1% |
| 营业利润率 | 18.5% | -14.5% |
| 净利率 | 6.5% | -15.2% |
| 营收同比 | 5.3% | 6.2% |
| 净利润同比 | 7.8% | 66.0% |
| 每股收益（稀释后） | $0.35 | $-0.74 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVRGXRAY
| Q4 25 | $1.3B | $961.0M | ||
| Q3 25 | $1.8B | $904.0M | ||
| Q2 25 | $1.4B | $936.0M | ||
| Q1 25 | $1.3B | $879.0M | ||
| Q4 24 | $1.2B | $905.0M | ||
| Q3 24 | $1.8B | $951.0M | ||
| Q2 24 | $1.4B | $984.0M | ||
| Q1 24 | $1.3B | $953.0M |
净利润EVRGXRAY
| Q4 25 | $84.3M | $-146.0M | ||
| Q3 25 | $475.0M | $-427.0M | ||
| Q2 25 | $171.3M | $-45.0M | ||
| Q1 25 | $125.0M | $20.0M | ||
| Q4 24 | $78.2M | $-430.0M | ||
| Q3 24 | $465.6M | $-494.0M | ||
| Q2 24 | $207.0M | $-4.0M | ||
| Q1 24 | $122.7M | $18.0M |
毛利率EVRGXRAY
| Q4 25 | — | 46.1% | ||
| Q3 25 | — | 48.8% | ||
| Q2 25 | — | 52.4% | ||
| Q1 25 | — | 53.0% | ||
| Q4 24 | — | 49.3% | ||
| Q3 24 | — | 52.1% | ||
| Q2 24 | — | 51.9% | ||
| Q1 24 | — | 53.1% |
营业利润率EVRGXRAY
| Q4 25 | 18.5% | -14.5% | ||
| Q3 25 | 37.3% | -24.1% | ||
| Q2 25 | 25.4% | -13.7% | ||
| Q1 25 | 22.5% | 7.2% | ||
| Q4 24 | 18.1% | -56.2% | ||
| Q3 24 | 35.1% | -48.6% | ||
| Q2 24 | 25.4% | 5.1% | ||
| Q1 24 | 20.3% | 4.4% |
净利率EVRGXRAY
| Q4 25 | 6.5% | -15.2% | ||
| Q3 25 | 26.9% | -47.2% | ||
| Q2 25 | 12.6% | -4.8% | ||
| Q1 25 | 9.7% | 2.3% | ||
| Q4 24 | 6.4% | -47.5% | ||
| Q3 24 | 26.0% | -51.9% | ||
| Q2 24 | 14.7% | -0.4% | ||
| Q1 24 | 9.6% | 1.9% |
每股收益（稀释后）EVRGXRAY
| Q4 25 | $0.35 | $-0.74 | ||
| Q3 25 | $2.03 | $-2.14 | ||
| Q2 25 | $0.74 | $-0.22 | ||
| Q1 25 | $0.54 | $0.10 | ||
| Q4 24 | $0.34 | $-2.09 | ||
| Q3 24 | $2.02 | $-2.46 | ||
| Q2 24 | $0.90 | $-0.02 | ||
| Q1 24 | $0.53 | $0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $326.0M |
| 总债务越低越好 | — | $2.3B |
| 股东权益账面价值 | $10.2B | $1.3B |
| 总资产 | $33.9B | $5.4B |
| 负债/权益比越低杠杆越低 | — | 1.70× |
8季度趋势，按日历期对齐
现金及短期投资EVRGXRAY
| Q4 25 | $19.8M | $326.0M | ||
| Q3 25 | $27.5M | $363.0M | ||
| Q2 25 | $27.8M | $359.0M | ||
| Q1 25 | $35.3M | $398.0M | ||
| Q4 24 | $22.0M | $272.0M | ||
| Q3 24 | $34.6M | $296.0M | ||
| Q2 24 | $26.1M | $279.0M | ||
| Q1 24 | $63.7M | $291.0M |
总债务EVRGXRAY
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益EVRGXRAY
| Q4 25 | $10.2B | $1.3B | ||
| Q3 25 | $10.3B | $1.5B | ||
| Q2 25 | $10.0B | $2.0B | ||
| Q1 25 | $9.9B | $2.0B | ||
| Q4 24 | $10.0B | $1.9B | ||
| Q3 24 | $10.0B | $2.5B | ||
| Q2 24 | $9.7B | $3.1B | ||
| Q1 24 | $9.6B | $3.3B |
总资产EVRGXRAY
| Q4 25 | $33.9B | $5.4B | ||
| Q3 25 | $33.4B | $5.7B | ||
| Q2 25 | $32.9B | $6.1B | ||
| Q1 25 | $32.5B | $6.0B | ||
| Q4 24 | $32.3B | $5.8B | ||
| Q3 24 | $32.1B | $6.6B | ||
| Q2 24 | $31.8B | $6.9B | ||
| Q1 24 | $31.3B | $7.1B |
负债/权益比EVRGXRAY
| Q4 25 | — | 1.70× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $334.0M | $101.0M |
| 自由现金流经营现金流 - 资本支出 | $-530.5M | $60.0M |
| 自由现金流率自由现金流/营收 | -41.1% | 6.2% |
| 资本支出强度资本支出/营收 | 66.9% | 4.3% |
| 现金转化率经营现金流/净利润 | 3.96× | — |
| 过去12个月自由现金流最近4个季度 | $-751.7M | $104.0M |
8季度趋势，按日历期对齐
经营现金流EVRGXRAY
| Q4 25 | $334.0M | $101.0M | ||
| Q3 25 | $937.7M | $79.0M | ||
| Q2 25 | $323.9M | $48.0M | ||
| Q1 25 | $449.6M | $7.0M | ||
| Q4 24 | $395.6M | $87.0M | ||
| Q3 24 | $953.3M | $141.0M | ||
| Q2 24 | $317.5M | $208.0M | ||
| Q1 24 | $317.3M | $25.0M |
自由现金流EVRGXRAY
| Q4 25 | $-530.5M | $60.0M | ||
| Q3 25 | $225.4M | $40.0M | ||
| Q2 25 | $-303.4M | $16.0M | ||
| Q1 25 | $-143.2M | $-12.0M | ||
| Q4 24 | $-118.6M | $36.0M | ||
| Q3 24 | $427.0M | $98.0M | ||
| Q2 24 | $-360.0M | $156.0M | ||
| Q1 24 | $-301.3M | $-9.0M |
自由现金流率EVRGXRAY
| Q4 25 | -41.1% | 6.2% | ||
| Q3 25 | 12.8% | 4.4% | ||
| Q2 25 | -22.4% | 1.7% | ||
| Q1 25 | -11.1% | -1.4% | ||
| Q4 24 | -9.7% | 4.0% | ||
| Q3 24 | 23.9% | 10.3% | ||
| Q2 24 | -25.6% | 15.9% | ||
| Q1 24 | -23.5% | -0.9% |
资本支出强度EVRGXRAY
| Q4 25 | 66.9% | 4.3% | ||
| Q3 25 | 40.4% | 4.3% | ||
| Q2 25 | 46.3% | 3.4% | ||
| Q1 25 | 45.8% | 2.2% | ||
| Q4 24 | 41.9% | 5.6% | ||
| Q3 24 | 29.4% | 4.5% | ||
| Q2 24 | 48.1% | 5.3% | ||
| Q1 24 | 48.3% | 3.6% |
现金转化率EVRGXRAY
| Q4 25 | 3.96× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 1.89× | — | ||
| Q1 25 | 3.60× | 0.35× | ||
| Q4 24 | 5.06× | — | ||
| Q3 24 | 2.05× | — | ||
| Q2 24 | 1.53× | — | ||
| Q1 24 | 2.59× | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVRG
| Electric Utility Customer Class Residential | $462.9M | 36% |
| Electric Utility Customer Class Commercial | $447.6M | 35% |
| Electric Utility Customer Class Industrial | $164.1M | 13% |
| Electric Utility Customer Class Transmission | $129.4M | 10% |
| Electric Utility Customer Class Wholesale | $69.7M | 5% |
| Electric Utility Customer Class Other Retail | $12.2M | 1% |
| Electric Utility Customer Class Industrial Steam | $5.7M | 0% |
XRAY
| Essential Dental Solutions | $372.0M | 39% |
| Equipment And Instruments | $160.0M | 17% |
| Implants And Prosthetics | $150.0M | 16% |
| CADCAM | $139.0M | 14% |
| Wellspect Healthcare | $88.0M | 9% |
| Orthodontics | $52.0M | 5% |
